This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (46)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Pediatrics  • Adolescent Psychiatry  • Child Psychiatry  • Psychopharmacology  • Alert me on articles by topic

Mark Olfson, MD, MPH; Carlos Blanco, MD, PhD; Linxu Liu, PhD; Carmen Moreno, MD; Gonzalo Laje, MD

Arch Gen Psychiatry. 2006;63:679-685.

Context  Although there are indications that antipsychotic drugs are increasingly used to treat children and adolescents, little is known about the characteristics of those who receive them.

Objective  To examine national trends and patterns in antipsychotic treatment of youth seen by physicians in office-based medical practice.

Design  Analysis of national trends of visits (1993-2002) that included prescription of antipsychotics, and comparison of the clinical and demographic characteristics of visits (2000-2002) that included or did not include antipsychotic treatment.

Setting  Outpatient visits to physicians in office-based practice.

Participants  Patient visits by persons 20 years and younger from the National Ambulatory Medical Care Surveys from 1993 to 2002.

Main Outcome Measures  Visits that included prescription of antipsychotics.

Results  In the United States, the estimated number of office-based visits by youth that included antipsychotic treatment increased from approximately 201 000 in 1993 to 1 224 000 in 2002. From 2000 to 2002, the number of visits that included antipsychotic treatment was significantly higher for male youth (1913 visits per 100 000 population) than for female youth (739 visits per 100 000 population), and for white non-Hispanic youth (1515 visits per 100 000 population) than for youth of other racial or ethnic groups (426 visits per 100 000 population). Overall, 9.2% of mental health visits and 18.3% of visits to psychiatrists included antipsychotic treatment. From 2000 to 2002, 92.3% of visits with prescription of an antipsychotic included a second-generation medication. Mental health visits with prescription of an antipsychotic included patients with diagnoses of disruptive behavior disorders (37.8%), mood disorders (31.8%), pervasive developmental disorders or mental retardation (17.3%), and psychotic disorders (14.2%).

Conclusions  There has been a sharp national increase in antipsychotic treatment among children and adolescents in office-based medical practice. Second-generation antipsychotics are being widely prescribed, and emerging empirical evidence provides a base of support that is limited to short-term safety and efficacy.

Author Affiliations: New York State Psychiatric Institute and Department of Psychiatry, College of Physicians and Surgeons (Drs Olfson, Blanco, Liu, and Moreno), and Department of Biostatistics, Mailman School of Public Health (Dr Liu), Columbia University, New York; and Genetic Basis of Mood and Anxiety Disorders, Mood and Anxiety Program, National Institute of Mental Health, Bethesda, Md (Dr Laje).

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Changing Trends in Pediatric Antipsychotic Use in Florida's Medicaid Program
Constantine and Tandon
Psychiatr. Serv. 2008;59:1162-1168.
ABSTRACT | FULL TEXT  

Pharmacologic Treatment of Posttraumatic Stress Disorder Among Privately Insured Americans
Harpaz-Rotem et al.
Psychiatr. Serv. 2008;59:1184-1190.
ABSTRACT | FULL TEXT  

Metabolic and Cardiovascular Adverse Events Associated With Antipsychotic Treatment in Children and Adolescents
McIntyre and Jerrell
Arch Pediatr Adolesc Med 2008;162:929-935.
ABSTRACT | FULL TEXT  

Use of Multiple Psychotropic Medications Among Adolescents Aging Out of Foster Care
Raghavan and McMillen
Psychiatr. Serv. 2008;59:1052-1055.
ABSTRACT | FULL TEXT  

Medical and Mental Health of Children Entering the Utah Foster Care System
Steele and Buchi
Pediatrics 2008;122:e703-e709.
ABSTRACT | FULL TEXT  

A Preliminary Attempt to Personalize Risperidone Dosing Using Drug-Drug Interactions and Genetics: Part II
de Leon et al.
Psychosomatics 2008;49:347-361.
FULL TEXT  

Antipsychotic Use in Children and Adolescents: Minimizing Adverse Effects to Maximize Outcomes
Correll
Focus 2008;6:368-378.
ABSTRACT | FULL TEXT  

Who Are the New Users of Antipsychotic Medications?
Domino and Swartz
Psychiatr. Serv. 2008;59:507-514.
ABSTRACT | FULL TEXT  

Use of Antipsychotic Drugs Among Dutch Youths Between 1997 and 2005
Kalverdijk et al.
Psychiatr. Serv. 2008;59:554-560.
ABSTRACT | FULL TEXT  

A Preliminary Attempt to Personalize Risperidone Dosing Using Drug-Drug Interactions and Genetics: Part I
de Leon et al.
Psychosomatics 2008;49:258-270.
ABSTRACT | FULL TEXT  

Epidemiologic Features of Antipsychotic Prescribing to Children and Adolescents in Primary Care in the United Kingdom
Rani et al.
Pediatrics 2008;121:1002-1009.
ABSTRACT | FULL TEXT  

Incarceration and Psychotropic Drug Use by Youth
Cuellar et al.
Arch Pediatr Adolesc Med 2008;162:219-224.
ABSTRACT | FULL TEXT  

Bibliography Schizophrenia
Focus 2008;6:197-199.
FULL TEXT  

Abstracts
Focus 2008;6:200-204.
FULL TEXT  

Pharmacotherapy and child psychiatry: is there a way forward?: INVITED COMMENTARY ON... CHILD PSYCHIATRY AND ITS RELATIONSHIP WITH THE PHARMACEUTICAL INDUSTRY
James
Adv. Psychiatr. Treat. 2008;14:10-16.
ABSTRACT | FULL TEXT  

Olanzapine Versus Placebo in the Treatment of Adolescents With Bipolar Mania
Tohen et al.
Am. J. Psychiatry 2007;164:1547-1556.
ABSTRACT | FULL TEXT  

National Trends in the Outpatient Diagnosis and Treatment of Bipolar Disorder in Youth
Moreno et al.
Arch Gen Psychiatry 2007;64:1032-1039.
ABSTRACT | FULL TEXT  

Medicaid's Prior Authorization Program And Access To Atypical Antipsychotic Medications
Polinski et al.
Health Aff (Millwood) 2007;26:750-760.
ABSTRACT | FULL TEXT  

Risperidone (Risperdal)
JWatch Pediatrics 2007;2007:4-4.
FULL TEXT  

Gaining: Pediatric Patients and Use of Atypical Antipsychotics
Towbin
Am. J. Psychiatry 2006;163:2034-2036.
FULL TEXT  

Risperidone maintenance treatment increases time to symptom recurrence in young people with disruptive behaviour disorders.
Vitiello
Evid. Based Ment. Health 2006;9:105-105.
FULL TEXT  

Pediatric Antipsychotic Prescription Rates Soar
Schonwald
AAP Grand Rounds 2006;16:25-26.
FULL TEXT  

Increasing Use of Second-Generation Antipsychotics in Children and Adolescents
JWatch Pediatrics 2006;2006:1-1.
FULL TEXT  

Rational prescribing for children.
Sutcliffe and Wong
BMJ 2006;332:1464-1465.
FULL TEXT  

Pediatric Treatment with Antipsychotic Drugs
JWatch Psychiatry 2006;2006:1-1.
FULL TEXT  

Antipsychotic use among US young people has risen sixfold.
Tanne
BMJ 2006;332:1407-1407.
FULL TEXT